QS-21 Adjuvant: Laboratory-Scale Purification Method and Formulation Into Liposomes.

Détails

Ressource 1Télécharger: 5_27718186_Postprint.pdf (1032.88 [Ko])
Etat: Public
Version: Author's accepted manuscript
ID Serval
serval:BIB_AF425E56083A
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Titre
QS-21 Adjuvant: Laboratory-Scale Purification Method and Formulation Into Liposomes.
Périodique
Methods in molecular biology
Auteur(s)
Brunner L., Barnier-Quer C., Collin N.
ISSN
1940-6029 (Electronic)
ISSN-L
1064-3745
Statut éditorial
Publié
Date de publication
2017
Peer-reviewed
Oui
Volume
1494
Pages
73-86
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
QS-21, a saponin extracted from the tree Quillaja saponaria Molina, is a vaccine adjuvant which has been shown to elicit robust antibody and cell-mediated immune responses in a variety of preclinical and clinical studies [1]. Its purification from the natural source is a lengthy and difficult process. The commercially available saponin mixture Quil-A® is a fraction of the bark extract containing a variety of saponins, including QS-21. In order to facilitate access to QS-21 at laboratory-scale amounts, we propose here a method of purification of QS-21 starting from Quil-A®. In addition, we describe a protocol to appropriately formulate QS-21 into cholesterol-containing, neutral liposomes which are known to decrease QS-21's hemolytic activity while retaining the adjuvant effect. Methods for the physicochemical characterization of purified QS-21 and of the QS-21/liposome formulations are also described.

Mots-clé
Adjuvants, Immunologic/chemical synthesis, Adjuvants, Immunologic/chemistry, Adjuvants, Immunologic/isolation & purification, Adjuvants, Immunologic/pharmacology, Animals, Liposomes, Mice, Saponins/chemical synthesis, Saponins/chemistry, Saponins/isolation & purification, Saponins/pharmacology, QS-21, Saponin, Vaccine adjuvant
Pubmed
Open Access
Oui
Création de la notice
19/10/2016 13:27
Dernière modification de la notice
20/08/2019 16:18
Données d'usage